TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05424848

Intervention type: OTHER
Intervention: Ultasonographic measurement
Description: Ultrasonographic measurements of the patients will be evaluated by Dr. Merve Damla Korkmaz. Patients will be positioned in a semi-dark room with the knees fully flexed. Ultrasonographic measurements will be made to evaluate the femoral cartilage thickness of both knees, with images taken from the suprapatellar axillary position. Images of the intercondylar area, lateral and medial femoral condyles of the right and left knees will be taken and the measurements will be made from these areas, 3 measurements will be taken from each knee and the average of these measurements will be taken.

Intervention type: OTHER
Intervention: Ultasonographic measurement
Description: Ultrasonographic measurements of the patients will be evaluated by Dr. Merve Damla Korkmaz. Patients will be positioned in a semi-dark room with the knees fully flexed. Ultrasonographic measurements will be made to evaluate the femoral cartilage thickness of both knees, with images taken from the suprapatellar axillary position. Images of the intercondylar area, lateral and medial femoral condyles of the right and left knees will be taken and the measurements will be made from these areas, 3 measurements will be taken from each knee and the average of these measurements will be taken.
Study: NCT05189652

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release and Exercise Group
Description: The exercise program will be applied 3 days a week for 4 weeks. Participants will warm up by walking for 5 minutes before exercise. Stretching exercises - Reach forward with sitting and hamstring (3 reps\*30 sec).~First 2 weeks:~Squat exercise (3 sets of 10 reps). Standing on one leg with knee flexed and hip-knee flexed at 90 degrees (30 seconds).~Star Excursion balance training (2 rounds to be applied). Foam Roller massage will apply to thoracolumbar posterior chain (1 set of 30 seconds will be applied with a rolling period of 2-4 seconds).~Last 2 weeks:~Squat exercise (3 sets of 15 reps). Standing on one leg with knee flexed and hip-knee flexed at 90 degrees (40 seconds).~Star Excursion balance training (3 rounds to be applied). Foam Roller massage will apply to thoracolumbar posterior chain (2 sets of 30 seconds will be applied to each area with a rolling period of 2-4 seconds).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Group
Description: The exercise program will be applied 3 days a week for 4 weeks. Participants will warm up by walking for 5 minutes before exercise. Stretching exercises- Reach forward with sitting and hamstring (3 reps\*30 sec).~First 2 weeks:~Squat exercise (3 sets of 10 reps). Standing on one leg with knee flexed and hip-knee flexed at 90 degrees (30 seconds).~Star Excursion balance training (2 rounds to be applied).~Last 2 weeks:~Squat exercise (3 sets of 15 reps). Standing on one leg with knee flexed and hip-knee flexed at 90 degrees (40 seconds).~Star Excursion balance training (3 rounds to be applied).
Study: NCT04832594

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI selection for supplemental breast MRI
Description: An AI tool will generate scores used to determine eligibility. Women randomized to MRI will be examined in an MRI scanner.
Study: NCT06444776

Intervention type: DIAGNOSTIC_TEST
Intervention: Repetitive (semi-)objective and subjective taste, smell, and saliva analysis
Description: Study participants will undergo repetitive assessments of their taste, smell and saliva, using quality of life questionnaires, taste strips, sniffin sticks, and analysis of salivary function and composition.~Assessments will be done before treatment, in the 4th week (+/- 1 week) and last week of radiation therapy (+/- 1 week), and at 6 months (+/- 1 months) and 1 and 2 years post-therapy (+/- 3 months).~At the minimum, participants are expected to complete the assessments at baseline and 1 year after the end of radiation therapy. Assessments at all other time points are strongly encouraged but will be optional.
Study: NCT06577233

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride
Description: 10cc of 0.25% Bupivacaine Hydrochloride will be injected into the peritoneum overlying the superior hypogastric nerve plexus with a laparoscopic needle during robotic surgery

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: 10cc of 0.9% normal saline will be injected into the peritoneum overlying the superior hypogastric nerve plexus with a laparoscopic needle during robotic surgery
Study: NCT04514913

Intervention type: RADIATION
Intervention: Multidetector Computed Tomography (MDCT) Scan
Description: This is a low-dose CT scan of the chest using no contract material.

Intervention type: RADIATION
Intervention: Multidetector Computed Tomography (MDCT) Scan
Description: This is a low-dose CT scan of the chest using no contract material.

Intervention type: RADIATION
Intervention: Multidetector Computed Tomography (MDCT) Scan
Description: This is a low-dose CT scan of the chest using no contract material.

Intervention type: PROCEDURE
Intervention: Virtual Navigation Bronchoscopy (VNB)
Description: This is a procedure where a camera will be inserted into the lung in order to guide sample collection of bronchoalveolar lavages, bronchail brushes and endobronchial biopsies.

Intervention type: PROCEDURE
Intervention: Virtual Navigation Bronchoscopy (VNB)
Description: This is a procedure where a camera will be inserted into the lung in order to guide sample collection of bronchoalveolar lavages, bronchail brushes and endobronchial biopsies.

Intervention type: PROCEDURE
Intervention: Virtual Navigation Bronchoscopy (VNB)
Description: This is a procedure where a camera will be inserted into the lung in order to guide sample collection of bronchoalveolar lavages, bronchail brushes and endobronchial biopsies.
Study: NCT05921578

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pre-operative planning based on CBCT
Description: Pre-operative planning based on CBCT
Study: NCT05460013

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Traditional Control
Description: Placebo control is a compounded made-up shake that is traditionally used by the Haematology ward to supplement patients receiving HSCT. The control provides an equivalent of 500kcals and 20.6g protein, 3.4g fiber per day. The participants will be randomly assigned to consume the control twice daily for the duration of 7 days prior to the admission to the day of discharge.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplement
Description: The product to be studied is a standard polymeric formula. It is intended to provide 500cals, 18.4g protein, and 5g fiber per day. The fiber contained is mostly presented in the form of soluble fiber (inulin, fructo-oligosaccharide). The participants will be randomly assigned to consume the intervention twice a day for the duration of 7 days prior to the admission to the day of discharge.
Study: NCT06482970

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise plus pain neuroscience education
Description: The exercises follow neuromuscular principles, which aim to improve sensorimotor control and achieve compensatory functional stability (also called dynamic stability).~Pain neuroscience education will take an active, person-centered approach through their own fear-avoidance beliefs.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular exercise
Description: The exercises follow neuromuscular principles, which aim to improve sensorimotor control and achieve compensatory functional stability (also called dynamic stability).
Study: NCT04969952

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: For interventional module
Description: Using vedio to assist physicians introducing advance care planning to cancer patients

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: For interventional module
Description: Using vedio to assist physicians introducing advance care planning to cancer patients
Study: NCT05378672

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasiglucagon
Description: Dasiglucagon, 0.6 mg/0.6 mL or 0.3 mg/0.3 mL will be administered as an under the skin (subcutaneous, s.c.) injection by a prefilled syringe, into the buttocks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasiglucagon
Description: Dasiglucagon, 0.6 mg/0.6 mL or 0.3 mg/0.3 mL will be administered as an under the skin (subcutaneous, s.c.) injection by a prefilled syringe, into the buttocks.
Study: NCT05373251

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Whole genomic DNA/RNA tumour sequencing
Description: All participants will undergo pre-radiotherapy fresh core biopsies of the tumour. DNA libraries will be created and stored for future analysis.~Participants with recurrence will have biopsy and subsequently will undergo rapid sequencing of RNA and DNA followed by bioinformatic analysis to identify somatic mutations or other abnormalities that might be drivers of an individual's cancer or predict response to therapies. These data will be compared to the literature and to a comprehensive database of drugs with the aim of identifying drugs most likely to target individual tumors based on the presence of mutated or abnormally expressed genes in the tumor. Any palliative systemic therapy treatment would be closely monitored for tolerability and response, as part of the general clinical care of someone on systemic therapy. The choice of systemic therapy will be up to the treating medical oncologist and the patient.
Study: NCT06131866

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation based on Acceptance and Commitment Therapy
Description: Acceptance and Commitment Therapy Based Psychoeducation will be applied to the patients in the intervention group in the form of group education (consisting of 5-7 people), one session per week for eight weeks; no intervention will be applied to the control group.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation based on Acceptance and Commitment Therapy
Description: Acceptance and Commitment Therapy Based Psychoeducation will be applied to the patients in the intervention group in the form of group education (consisting of 5-7 people), one session per week for eight weeks; no intervention will be applied to the control group.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation based on Acceptance and Commitment Therapy
Description: Acceptance and Commitment Therapy Based Psychoeducation will be applied to the patients in the intervention group in the form of group education (consisting of 5-7 people), one session per week for eight weeks; no intervention will be applied to the control group.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation based on Acceptance and Commitment Therapy
Description: Acceptance and Commitment Therapy Based Psychoeducation will be applied to the patients in the intervention group in the form of group education (consisting of 5-7 people), one session per week for eight weeks; no intervention will be applied to the control group.
Study: NCT06195917

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic-assisted Interventional Percutaneous transhepatic puncture
Description: Robotic-assisted Interventional Percutaneous transhepatic puncture
Study: NCT05999955

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neomycin/ Dexameythasone/Xylometazoline
Description: The active-control in the phase II study was a commercial form of nasal spray containing Dexamethasone/Neomycin/Xylometazoline. This formulation is approved by Vietnam's Ministry of Health as a treatment regime for rhinosinusitis. Dexamethasone sodium phosphate is fluoromethyl prednisolone, a synthetic glucocorticoid. Dexamethasone has the main effects of glucocorticoids as anti-inflammatory, antiallergic and immunosuppressant. Neomycin sulfate is an antibiotic belonging to the group of aminoglycosides that have a bactericidal mechanism due to inhibition of bacterial protein biosynthesis. In this study, the nasal spray is used as an adjunct to Amoxicillin/Clavulanate standard treatment

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis DSM32444
Description: Postbiotic DSM32444 is manufactured by HURO BIOTECH Company as a drug-grade active pharmaceutical ingredient. The Class A medical device containing Postbiotic DSM32444 is called Sperovid, which is manufactured by Dong Duoc Viet under ISO 13485:2016 standards for medical device. Sperovid has registration number: 220000033/ PCBALA In this study, the nasal spray is used as an adjunct to Amoxicillin/Clavulanate standard treatmen.
Study: NCT04460742

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CAPABLE Transitions
Description: The CAPABLE Transitions intervention group will receive an occupational therapy-led multidisciplinary in-home intervention in which the study occupational therapist (\<6 visits), registered nurse (\<5 visits), and handyman (\<2 visits) work with participants over 3-4 months. This intervention group also will receive home health agency care as usual services. CAPABLE Transitions in embedded within a home health agency and includes a care transitions emphasis.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Health Agency Care
Description: Both the CAPABLE Transitions intervention and care as usual treatment arms will receive home health agency care as usual services, which can include nursing, health aide, medical social work, and occupational, physical, and speech therapy services. Home health agency clinicians will determine the types and duration of CHHA services that the study participants receive; these services will be completely independent from the research study.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home Health Agency Care
Description: Both the CAPABLE Transitions intervention and care as usual treatment arms will receive home health agency care as usual services, which can include nursing, health aide, medical social work, and occupational, physical, and speech therapy services. Home health agency clinicians will determine the types and duration of CHHA services that the study participants receive; these services will be completely independent from the research study.
Study: NCT05527054

Intervention type: OTHER
Intervention: Diuretics
Description: Inpatients using diuretics

Intervention type: OTHER
Intervention: Diuretics
Description: Inpatients using diuretics
Study: NCT05115721

Intervention type: OTHER
Intervention: no intervention
Description: It's only observational study. No interventions.

Intervention type: OTHER
Intervention: no intervention
Description: It's only observational study. No interventions.
Study: NCT06353386

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opevesostat
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opevesostat
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opevesostat
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opevesostat
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: IV Infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Description: IV Infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Oral Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Oral Tablet
Study: NCT05826587

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based, m-Health Delivered Physical Function Training
Description: An individualized home exercise physical function training will be prescribed. This would include 5 balance training exercises and 1-2 upper and lower-body muscular conditioning exercises (i.e., wall push-up and chair stand) prescribed 3 days/week over the course of a 6-week period. Subjects will be assigned exercises from 1 of 3 different levels of exercise progression based on performance during the baseline muscular fitness assessment (functional chair stand and static chest throw).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac Rehabilitation & Exercise Prescription
Description: Standard, clinically indicated cardiac rehabilitation and exercise program. Approximately 30 to 40 minutes of aerobic exercise within a prescribed rating of perceived exertion (RPE 11-14) and/or target heart rate and approximately 15 to 20 minutes of both upper and lower body resistance exercise up to three times per week for up to at least 12 weeks. In addition, subjects are provided with home exercise instructions, and will be expected to exercise for 30 to 60 minutes at home.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation & Exercise Prescription
Description: Standard, clinically indicated cardiac rehabilitation and exercise program. Approximately 30 to 40 minutes of aerobic exercise within a prescribed rating of perceived exertion (RPE 11-14) and/or target heart rate and approximately 15 to 20 minutes of both upper and lower body resistance exercise up to three times per week for up to at least 12 weeks. In addition, subjects are provided with home exercise instructions, and will be expected to exercise for 30 to 60 minutes at home.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Connected mHealth mobile application
Description: Mobile application that allows subjects to track their independent home exercise with the option of heart rate monitoring by connecting to an external heart rate monitoring device.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Connected mHealth mobile application
Description: Mobile application that allows subjects to track their independent home exercise with the option of heart rate monitoring by connecting to an external heart rate monitoring device.
Study: NCT05922345

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
Description: AL2846 capsules is a multi-targeted small molecule receptor tyrosine kinase inhibitor.~TQB2450 Injection is an anti-programmed death-1 (PD-L1).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQB2450 placebo, docetaxel injection, AL2846 matching placebo
Description: Docetaxel injection is a type of chemotherapy for treatment of different types of cancer.
Study: NCT06120764

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: guided imagery
Description: The children in the experimental group will listen to the first part of the 'Guided Imagery CD' prepared by the Turkish Psychological Association for relaxation 30 minutes before the chemotherapy infusion starts. The suggestions given in the first part of the CD will help the patients relax and focus their attention on their breathing. Patients will be positioned in a supine or semi-fowler position and will listen to the CD with headphones from a laptop. Once the chemotherapy infusion starts, relaxing light background music with the sound of a river or sea will be played based on the patients' preference, and imagery will be applied to the patients. Patients will be encouraged to think of various images, such as imagining that the treatment is over, visualizing themselves as much healthier and recovering quickly, returning to their old life, and doing whatever they want to do first after recovery. If there is an object, person, event, situation, or food that will make them feel good,
Study: NCT06491563

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BRII-179
Description: BRII-179 will be given via intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BRII-179
Description: BRII-179 will be given via intramuscular injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BRII-835 (VIR-2218)
Description: BRII-835 will be given via subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BRII-835 (VIR-2218)
Description: BRII-835 will be given via subcutaneous injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PEG-IFNα
Description: PEG-IFNα will be given via subcutaneous injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PEG-IFNα
Description: PEG-IFNα will be given via subcutaneous injection
Study: NCT05465499

Intervention type: PROCEDURE
Intervention: ERAS
Description: This study is a cross-sectional observational study by distributing questionnaires regarding the readiness to implement ERAS at Dr Soetomo General Hospital to the subjects, so there is no treatment whatsoever on the subjects.
Study: NCT01170871

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixabepilone
Study: NCT06021795

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sound Treatment
Description: Customized sound audio track delivered via standard commercially available bone conduction headset
Study: NCT05345613

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Submucosal injection of standard solution including TXA during EMR procedure

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Standard
Description: Injection of standard solution